Identification of hotspot residues in the FusB:EF-G binding interface
Biophysical Journal · 2026-11 · 125 (21) · 6165-6180
DOI: 10.1016/j.bpj.2026.09.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Journal, 2026-11. Verfasst von Anastasija Kulik und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK; Astbury Centre for Structural Biology, Univ…. Hauptthemen laut MEDLINE: Peptide Elongation Factor G, Bacterial Proteins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, The Royal Society.
Abstract (Originalsprache)
With a lack of new antimicrobials recently entering the clinic, another tactic to combat antimicrobial resistance is to inhibit the resistance mechanisms to existing antibiotics, prolonging the usefulness of these important drugs. One key clinical antibiotic is fusidic acid, which inhibits bacterial protein synthesis by binding to elongation factor G (EF-G) on the ribosome and preventing its release, stalling protein synthesis. The FusB family of proteins binds to EF-G and confers fusidic acid resistance by promoting the dissociation of these stalled complexes. This resistance mechanism could be inhibited by preventing EF-G:FusB binding, but protein-protein interactions are difficult drug targets due to the large interaction surface. Here, we use alanine scanning mutagenesis alongside surface plasmon resonance (SPR) and nuclear magnetic resonance (NMR) to identify residues within the interaction interface that have significant effects on the affinity of the interaction, allowing a hotspot to be identified that could be a potential target for inhibitor design. Furthermore, using a fluorescence-based assay, we show that reduced but not abolished binding affinity is sufficient to prevent FusB-mediated resistance in vitro. Our data therefore suggest a more tractable target for the design of inhibitors of FusB-mediated resistance, which could rejuvenate the use of this important antibiotic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK; Astbury Centre for Structural Biology, University of Leeds, Leeds, UK.
- Astbury Centre for Structural Biology, University of Leeds, Leeds, UK; School of Chemistry, University of Birmingham, Birmingham, UK; School of Chemistry, University of Leeds, Leeds, UK.
- School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK; Astbury Centre for Structural Biology, University of Leeds, Leeds, UK. Electronic address: j.h.tomlinson@leeds.ac…
Förderung
- Biotechnology and Biological Sciences Research Council
- The Royal Society
Zitieren
APA
Kulik, A., Manfield, I., Kalverda, A. P., Wilson, A., & Tomlinson, J. H. (2026). Identification of hotspot residues in the FusB:EF-G binding interface. Biophysical Journal, 125(21), 6165-6180. https://doi.org/10.1016/j.bpj.2026.09.033
Vancouver
Kulik A, Manfield I, Kalverda AP, Wilson A, Tomlinson JH. Identification of hotspot residues in the FusB:EF-G binding interface. Biophysical Journal. 2026;125(21):6165-6180. doi:10.1016/j.bpj.2026.09.033
BibTeX
@article{Kulik2026,
author = {Kulik, Anastasija and Manfield, Iain and Kalverda, Arnout P and Wilson, Andrew and Tomlinson, Jennifer H},
title = {Identification of hotspot residues in the FusB:EF-G binding interface},
journal = {Biophysical Journal},
year = {2026},
volume = {125},
number = {21},
pages = {6165--6180},
doi = {10.1016/j.bpj.2026.09.033}
}
EUVIMED